A recent study revealed that eRNA (CRISPR-Cas9) can control the oncogenic activity of the MYB and DCTD genes and is a key determinant of B-cell precursor acute lymphoblastic leukemia (B-ALL) [9]. The gene discussed is DCTD; the disease is precursor B-cell acute lymphoblastic leukemia.